Association between regional brain volumes and clozapine response in schizophrenia

Biological Psychiatry
J LaurielloA Pfefferbaum


Clozapine has shown considerable therapeutic promise in the treatment of schizophrenia; however, the clinical risks and initial high treatment costs associated with its administration motivate the search to identify patients who will best respond. Neuroimaging studies have suggested that prefrontal sulcal prominence may be a predictor of nonresponsiveness. We used magnetic resonance imaging (MRI) to test whether volumes in any cortical regions of the brain were associated with symptom improvement with clozapine treatment. The 21 schizophrenic men studied were clinically evaluated during treatment with typical neuroleptics (baseline) and after a mean of 6.2 months treatment with clozapine (final dose 300-900, median = 562 mg/day). At least a 20% improvement on total Brief Psychiatric Rating Scale (BPRS) was seen in 47.6% of the schizophrenics. Clinical improvement was regressed on baseline differences in clinical severity, and the residual scores were related to MRI values. Patients with larger anterior superior temporal lobe cerebrospinal fluid volumes (primarily sylvian fissure) showed greater improvement on total BPRS and withdrawal/retardation symptoms. Even schizophrenics with significant brain dysmorphology can have a posi...Continue Reading


Dec 3, 1992·The New England Journal of Medicine·A Klimke, S Knecht
Dec 1, 1992·Alcoholism, Clinical and Experimental Research·A PfefferbaumE V Sullivan
Mar 1, 1992·Archives of General Psychiatry·R B ZipurskyA Pfefferbaum
Aug 11, 1992·Archives of General Psychiatry·J B WilliamsB Rounsaville
Mar 14, 1991·The New England Journal of Medicine·R J Baldessarini, F R Frankenburg
Jan 1, 1992·Journal of Gerontology·K O LimA Pfefferbaum
Jul 1, 1989·Journal of Computer Assisted Tomography·K O Lim, A Pfefferbaum
Dec 1, 1994·The American Journal of Psychiatry·J A LiebermanJ M Kane
Nov 1, 1993·The American Journal of Psychiatry·H Y MeltzerB Snitz
Dec 1, 1993·Hospital & Community Psychiatry·A BreierW T Carpenter
Jun 1, 1994·The American Journal of Psychiatry·T E SchlaepferG D Pearlson
Aug 1, 1993·Psychological Medicine·I HarveyR M Murray
Jun 1, 1993·Schizophrenia Research·K KuoppasalmiE Leinonen
Jun 1, 1993·Psychiatry Research·D H MathalonA Pfefferbaum
Aug 1, 1995·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·W G HonerS Altman
May 1, 1996·Schizophrenia Research·K O LimA Pfefferbaum
Oct 1, 1996·Biological Psychiatry·B T WoodsM T Tsuang
Aug 1, 1997·The British Journal of Psychiatry : the Journal of Mental Science·K J Aitchison, R W Kerwin
May 30, 1998·Cerebral Cortex·E V SullivanA Pfefferbaum

❮ Previous
Next ❯


Feb 18, 2005·Psychopharmacology·Carmen Chung, Gary Remington
Aug 22, 2002·Progress in Neuro-psychopharmacology & Biological Psychiatry·Eva CeskováMiroslav Lorenc
Apr 11, 2001·Schizophrenia Research·P E KonickiG E Jaskiw
Jun 18, 2004·International Clinical Psychopharmacology·Vicente MolinaTomás Palomo
Dec 31, 2010·European Archives of Psychiatry and Clinical Neuroscience·Vicente MolinaJuan Antonio Hernández-Tamames
Mar 8, 2016·The Lancet. Psychiatry·Elias MouchlianitisOliver D Howes
Aug 28, 2007·The Psychiatric Clinics of North America·Helio Elkis
Sep 29, 2007·Progress in Neuro-psychopharmacology & Biological Psychiatry·V MolinaM Desco
Sep 22, 2007·Journal of the American Academy of Child and Adolescent Psychiatry·Alexandra L SpornNitin Gogtay
Mar 20, 2003·Biological Psychiatry·Thomas GrunwaldChristian E Elger
May 25, 2016·The Psychiatric Clinics of North America·Helio Elkis, Peter F Buckley
Apr 27, 2011·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Ann-Christine EhlisAndreas J Fallgatter
Apr 19, 2011·Schizophrenia Research·Lena PalaniyappanPeter F Liddle
Jan 9, 2003·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·William W SeeleyOwen M Wolkowitz
Sep 25, 2007·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Jorge Henna Neto, Hélio Elkis
May 2, 2019·Frontiers in Pharmacology·Antonio VitaMassimo Gennarelli
Dec 25, 2007·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Helio Elkis, Herbert Y Meltzer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.